carbamates has been researched along with olaparib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, W; Chu, Y; Mach, RH; Makvandi, M; Mankoff, J; McDonald, ES; Zeng, C | 1 |
1 other study(ies) available for carbamates and olaparib
Article | Year |
---|---|
Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azabicyclo Compounds; Carbamates; Cell Death; Cell Line, Tumor; Drug Synergism; Epithelial Cells; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Inhibitory Concentration 50; Mice; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Receptors, sigma | 2017 |